$23.26
+0.59 (+2.60%)
Open$22.73
Previous Close$22.67
Day High$23.28
Day Low$22.69
52W High$25.15
52W Low$16.52
Volume—
Avg Volume781.2K
Market Cap1.66B
P/E Ratio3.29
EPS$5.94
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+68.4% upside
Current
$23.26
$23.26
Target
$39.16
$39.16
$23.99
$39.16 avg
$41.33
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 358.82M | 333.85M | 296.49M |
| Net Income | 236.55M | 198.08M | 100.45M |
| Profit Margin | 65.9% | 62.6% | 33.9% |
| EBITDA | 155.02M | 137.02M | 161.71M |
| Free Cash Flow | — | — | 84.32M |
| Rev Growth | +7.5% | +7.5% | +12.4% |
| Debt/Equity | 0.22 | 0.22 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |